Wechselwirkungen · Remsima
Remsima 100 mg powder for concentrate for solution for infusion · Abschnitt 4.5 · PDF-Seite 14
HOS-127136 · Präparat HOS-096377
It is recommended that live vaccines not be given concurrently with infliximab. It is also recommended that live vaccines not be given to infants after in utero exposure to infliximab for 12 months following birth. If infant infliximab serum levels are undetectable or infliximab administration was limited to the first trimester of pregnancy, administration of a live vaccine might be considered at an earlier timepoint if there is a clear clinical benefit for the individual infant (see section 4.4).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-05-08T11:20:00Z · SHA-256 5f1b2b895f1e310b8eb529b3b18f60969b899952e26ddab3cd95ccea13a0dd8b · Passage c36a4080afe80a0841752c4cf876ea2f7402359785b659a10d71aec1ef7eb4ab · Zeichen 755–1257 im Abschnitt